182 articles
New Study Shows Experimental Drug Targets Gut-Liver Connection to Treat MASH An experimental drug developed at Michigan Medicine has shown remarkable results in reversing severe...
WHO Issues New Recommendations for Reducing Cognitive Decline The World Health Organization (WHO) has released updated guidelines on reducing the risk of cognitive decline and...
New Study Links Popular Artificial Sweeteners to Faster Cognitive Decline A major new study published in July 2026 has raised serious concerns about the safety...
WHO Unveils Updated Guidelines to Combat Rising Dementia Rates Worldwide The World Health Organization (WHO) has officially launched the second edition of its Guidelines on...
CDC Report Reveals U.S. Death Rate Hit a Record Low in 2025 — Here Is What That Means for Your Health New provisional data from...
Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...
A major new scientific review published in Trends in Endocrinology & Metabolism has shed important light on how different types of dietary fat can either...
Gut Bacteria May Hold the Key to Why Obesity and Type 2 Diabetes Become So Hard to Reverse A sweeping new scientific review has mapped...
New Study Challenges Long-Held Beliefs About Moderate Drinking A landmark study published in the Journal of Studies on Alcohol and Drugs in June 2026 has...
A major study of 600,000 veterans finds GLP-1 weight loss drugs like Ozempic may reduce addiction risk and opioid overdose by up to 40%. New hope for addiction treatment.